...
机译:评论:接受雷莫西尤单抗治疗的癌症患者胃肠道穿孔的风险:随机对照试验的荟萃分析
Eli Lilly & Co, Indianapolis, IN USA;
Eli Lilly & Co, Bridgewater, NJ USA;
ramucirumab; gastrointestinal perforation; risk; cancer; meta-analysis; VEGFR/VEGF inhibitor;
机译:Risk of hypertension with anti-VEGF monoclonal antibodies in cancer patients: a systematic review and meta-analysis of 105 phase II/III randomized controlled trials
机译:Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials
机译:Incidence and risk of proteinuria associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis of randomized controlled trials
机译:Stereotactic Ablative Radiotherapy versus Lobectomy for Operable Stage I Non-small-cell Lung Cancer: A Pooled Analysis of Two Randomized Trials——胸外科医生的解读
机译:Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial